Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

Sovereign Pharma, a part of the Dadachanji Group of Companies, announced the successful commissioning of its new advanced isolator-based filling line, marking a major advancement in India’s sterile ...

Contract manufacturer Ajinomoto Bio-Pharma Services is bringing its AstraZeneca production team-up to the U.S. Already pitching in on AZ's small molecule manufacturing in Europe, the CDMO has signed ...

In 2023 the pharmaceutical industry continued to advance with new product streams brought online and advanced technologies further embedded in operations, but what’s next? The regulatory intelligence ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing of ...

SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...

Piramal Pharma Solutions (PPS), a CDMO based in India and part of Piramal Pharma, reports that it plans to invest $80 million to expand its Lexington, KY facility. The site, which specializes in ...

(MENAFN- GlobeNewsWire - Nasdaq) The fill-finish pharmaceutical contract manufacturing market is poised for growth, driven by the demand for specialized manufacturing of complex small molecule drugs.